What is the effect of albumin (human albumin) infusion on haemoglobin (Hb) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Effect of Albumin on Hemoglobin Levels

Albumin administration causes a significant hemoglobin dilution of approximately 5 g/L on average, with hemodilution effects lasting for at least 12 hours after administration. 1

Mechanism and Extent of Dilution

Albumin causes hemodilution through several mechanisms:

  1. Volume expansion effect:

    • 5% albumin expands plasma volume by approximately double the volume infused 2
    • 20% albumin (hyperoncotic) can expand plasma volume by 1.9-2.2 times the infused volume 3
  2. Distribution pattern:

    • When 5% albumin is infused, both plasma volume and interstitial fluid volume expand by approximately equal amounts 2
    • With normal saline, the expansion ratio of plasma to interstitial fluid is about 1:3 2
  3. Duration of effect:

    • Hemodilution from albumin persists for at least 12 hours after administration 1
    • Isooncotic albumin solution (5%, 25g in 500mL) may cause hemoglobin decreases greater than 8 g/L 1

Clinical Implications

Transfusion Considerations

  • The significant hemodilution effect may cause hemoglobin levels to drop below transfusion thresholds, potentially increasing the need for RBC transfusions 1
  • In surgical patients, 30 minutes after infusion of approximately 20 mL/kg of 5% albumin, only 38±21% of the volume remained in the intravascular space 4

Fluid Management

  • Albumin is recommended for specific clinical scenarios such as:
    • Large-volume paracentesis (>5L) at a dose of 6-8g per liter of fluid removed 5
    • Spontaneous bacterial peritonitis (1.5g/kg on day 1, followed by 1g/kg on day 3) 6, 5
    • Hepatorenal syndrome in combination with vasoconstrictors 5

Monitoring Recommendations

  • When administering albumin, especially in patients with borderline hemoglobin levels:
    • Monitor hemoglobin levels before and after administration
    • Be aware that the dilutional effect may be misinterpreted as blood loss
    • Consider the prolonged hemodilution effect when planning subsequent interventions

Factors Affecting Albumin Distribution

The extent of hemodilution varies based on:

  1. Patient condition:

    • Patients with hypoproteinemia experience greater loss of albumin to extravascular compartments 7
    • In septic patients, fluid may move from intracellular to extracellular space after albumin infusion 2
  2. Albumin concentration:

    • Hyperoncotic albumin (20%) has approximately 5 times stronger volume expansion effect than crystalloids 3
    • Isooncotic albumin (5%) causes more significant hemodilution than equivalent volumes of crystalloids 1
  3. Infusion rate and volume:

    • Rapid infusion of large volumes causes more pronounced immediate hemodilution 4
    • After experimental blood loss, infused albumin disappears at a rate of 45-106 mL per hour 7

Practical Applications

  • For paracentesis: When using albumin (6-8g/L of fluid removed) for large-volume paracentesis, expect hemoglobin dilution and monitor accordingly 6
  • For critical care: In ICU patients receiving albumin, anticipate a hemoglobin drop of approximately 5 g/L and consider this when evaluating for potential bleeding 1
  • For surgical patients: Be aware that only about 40% of infused albumin volume remains intravascular after 30 minutes 4

Understanding the hemoglobin-diluting effect of albumin is essential for proper interpretation of laboratory values and clinical decision-making regarding transfusion requirements.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.